FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Sunday

 

Parkinson's drug could prove to be new treatment for multiple sclerosis






















A drug used to treat Parkinson's disease may provide an effective new therapy for multiple sclerosis (MS), research suggests.

Early tests on mice show that benztropine stimulates the production of nerve-repairing cells.

Scientists hit on the drug after screening 100,000 compounds for their abilitly to trigger the development of cells that rebuild damaged myelin, the protective fatty sheath that surrounds nerve fibres.

MS is an autoimmune disease that causes the body's defences to attack myelin, causing symptoms ranging from mild tingling sensations to full blown paralysis.

Cells called oligodendrocytes are able to repair myelin, but their numbers decline sharply in patients with MS.

The research, reported in the journal Nature, showed that benztropine effectively causes the stem cell-like precursors of oligodendrocytes to mature into functional cells.

"We're excited about these results and are now considering how to design an initial clinical trial," said Dr Luke Lairson, from the Scripps Research Institute in La Jolla, California.

In mice bred to have an MS-like condition benztropine showed a powerful ability to prevent the disease developing. It was also effective once symptoms emerged, and virtually eliminated relapses. It complimented existing treatments such as interferon-beta and fingolimod, allowing doses to be dramatically lowered.

However the scientists stressed that benztropine has adverse side effects and is yet to be proven safe for MS patients. "People shouldn't start using it off-label for MS," said Dr Lairson.

Story Source: The above story is based on materials provided by THEGUARDIAN
Note: Materials may be edited for content and length
Click here to read original article


Go to Newer News Go to Older News